Press Releases for June 24, 2020
advertisement
- Provention Bio’s Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
- Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes
- Lilly launches program about what people with diabetes should “Know Before the Low™”